ENDPOINTS

Leo Pharma says its yearslong makeover is about to pay off

For the first time since 2018, dermatology-focused Leo Pharma forecasts it could turn a profit this year. Its Wednesday guidance comes on the heels of a broad, multi-year restructuring — a plan that ...

Feb 26, 2025 - 09:02
 0
Leo Pharma says its yearslong makeover is about to pay off
For the first time since 2018, dermatology-focused Leo Pharma forecasts it could turn a profit this year. Its Wednesday guidance comes on the heels of a broad, multi-year restructuring — a plan that ...
Read More

Tags:

Previous Article

How Can Auto Dealerships Evolve During The EV Transition?

Next Article

How Jocelyn Bell once made a discovery that changed the field of astronomy

Related Posts

Biogen gets $250M in Royalty Pharma deal for lupus program

Biogen gets $250M in Royalty Pharma deal for lupus program

Feb 12, 2025  0

Achira raises $33M Nvidia-backed seed round, blending AI and physics in biotech

Achira raises $33M Nvidia-backed seed round, blending A...

Feb 21, 2025  0

EG 427 collects €27M in Series B to advance overactive bladder treatment

EG 427 collects €27M in Series B to advance overactive ...

Feb 20, 2025  0